Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects

NCT02710630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran etexilate tablet E1
DRUG: Dabigatran etexilate tablet D1
DRUG: Dabigatran etexilate tablet C1
DRUG: Dabigatran etexilate tablet B1
DRUG: Dabigatran etexilate tablet A1
DRUG: Dabigatran etexilate capsule

Sponsor

Boehringer Ingelheim